CLYM
Climb Bio Inc.

215
Mkt Cap
$125.46M
Volume
164,980.00
52W High
$3.30
52W Low
$1.05
PE Ratio
-2.45
CLYM Fundamentals
Price
$1.75
Prev Close
$1.84
Open
$1.86
50D MA
$2.01
Beta
0.92
Avg. Volume
958,398.78
EPS (Annual)
-$1.53
P/B
0.71
Rev/Employee
$0.00
Loading...
Loading...
News
all
press releases
Brokers Offer Predictions for Climb Bio FY2027 Earnings
Climb Bio, Inc. (NASDAQ:CLYM - Free Report) - Stock analysts at William Blair reduced their FY2027 earnings per share (EPS) estimates for Climb Bio in a report issued on Monday, November 10th...
MarketBeat·7d ago
News Placeholder
More News
News Placeholder
Nan Fung Trinity HK Ltd. Buys Shares of 463,654 Climb Bio, Inc. $CLYM
Nan Fung Trinity HK Ltd. purchased a new position in Climb Bio, Inc. (NASDAQ:CLYM - Free Report) in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange...
MarketBeat·7d ago
News Placeholder
Q1 Earnings Forecast for Climb Bio Issued By William Blair
Climb Bio, Inc. (NASDAQ:CLYM - Free Report) - Investment analysts at William Blair issued their Q1 2026 earnings per share (EPS) estimates for shares of Climb Bio in a report issued on Thursday...
MarketBeat·10d ago
News Placeholder
Climb Bio (NASDAQ:CLYM) Releases Earnings Results, Misses Estimates By $0.03 EPS
Climb Bio (NASDAQ:CLYM - Get Free Report) issued its quarterly earnings results on Thursday. The company reported ($0.19) earnings per share for the quarter, missing analysts' consensus estimates of...
MarketBeat·11d ago
News Placeholder
Is Climb Bio, Inc. (CLYM) Stock Outpacing Its Medical Peers This Year?
Here is how Climb Bio, Inc. (CLYM) and Idexx Laboratories (IDXX) have performed compared to their sector so far this year.
Zacks·2mo ago
News Placeholder
Climb Bio, Inc. (CLYM)'s Technical Outlook is Bright After Key Golden Cross
Should investors be excited or worried when a stock's 50-day simple moving average crosses above the 200-day simple moving average?
Zacks·3mo ago
News Placeholder
Is Climb Bio, Inc. (CLYM) Outperforming Other Medical Stocks This Year?
Here is how Climb Bio, Inc. (CLYM) and Cencora (COR) have performed compared to their sector so far this year.
Zacks·3mo ago
News Placeholder
SHAREHOLDER ALERT: Purcell and Lefkowitz LLP Announces Shareholder Investigation of Climb Bio, Inc. (NASDAQ: CLYM)
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Climb Bio, Inc. (NASDAQ: CLYM) SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of...
PR Newswire·11mo ago

Latest CLYM News

View

Advertisement|Remove ads.

Advertisement|Remove ads.